The Journal of Immunology, Vol 155, Issue 4 1818-1828, Copyright © 1995 by American Association of Immunologists

ARTICLES

Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells

JF Rowell, AL Ruff, FG Guarnieri, K Staveley-O'Carroll, X Lin, J Tang, JT August and RF Siliciano
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

A subset of endogenously synthesized Ags can be processed for class II- restricted presentation, probably through multiple mechanisms. Processing of exogenous Ags for class II-restricted presentation appears to occur in unique endosomal processing compartments with lysosomal characteristics including the presence of the lysosomal membrane protein LAMP-1. Therefore, we attempted to enhance the efficiency of class II-restricted presentation of an endogenous Ag, the HIV-1 envelope (env) protein, by specifically targeting the Ag to class II processing compartments through the pathway followed by LAMP-1. Because the env protein associates tightly with CD4 shortly after synthesis, we first targeted the env protein using a chimeric CD4 protein consisting of the extracellular domain of CD4 and the transmembrane and cytoplasmic domains of LAMP-1. When co-expressed with this chimeric protein, the env protein was efficiently localized to lysosome-like compartments. Enhanced stimulation of env-specific CD4+ T cell clones by APC expressing the env protein and the CD4-LAMP-1 chimera was readily demonstrated in both cytotoxicity assays and proliferation assays. We also targeted the env protein directly as a chimeric protein consisting of the extracellular domain of the env protein and the transmembrane and cytoplasmic domains of LAMP-1. The proliferative response of env-specific CD4+ T cell clones to the env- LAMP-1 chimera was greatly enhanced compared with wild-type env protein, especially when limiting numbers of stimulator cells were used. The enhanced stimulatory capacity of APC expressing LAMP-1- targeted Ags has important implications for vaccine design.

This article has been cited by other articles:

				L. Shi, P. C. Albuquerque, E. Lazar-Molnar, X. Wang, L. Santambrogio, A. Gacser, and J. D. Nosanchuk A Monoclonal Antibody to Histoplasma capsulatum Alters the Intracellular Fate of the Fungus in Murine Macrophages Eukaryot. Cell, July 1, 2008; 7(7): 1109 - 1117. [Abstract] [Full Text] [PDF]

				S. Kreiter, A. Selmi, M. Diken, M. Sebastian, P. Osterloh, H. Schild, C. Huber, O. Tureci, and U. Sahin Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals J. Immunol., January 1, 2008; 180(1): 309 - 318. [Abstract] [Full Text] [PDF]

				L. B. Arruda, D. Sim, P. R. Chikhlikar, M. Maciel Jr, K. Akasaki, J. T. August, and E. T. A. Marques Dendritic Cell-Lysosomal-Associated Membrane Protein (LAMP) and LAMP-1-HIV-1 Gag Chimeras Have Distinct Cellular Trafficking Pathways and Prime T and B Cell Responses to a Diverse Repertoire of Epitopes J. Immunol., August 15, 2006; 177(4): 2265 - 2275. [Abstract] [Full Text] [PDF]

				D. G. Kavanagh, D. E. Kaufmann, S. Sunderji, N. Frahm, S. Le Gall, D. Boczkowski, E. S. Rosenberg, D. R. Stone, M. N. Johnston, B. S. Wagner, et al. Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef Blood, March 1, 2006; 107(5): 1963 - 1969. [Abstract] [Full Text] [PDF]

				B. L. Granger, M. L. Flenniken, D. A. Davis, A. P. Mitchell, and J. E. Cutler Yeast wall protein 1 of Candida albicans Microbiology, May 1, 2005; 151(5): 1631 - 1644. [Abstract] [Full Text] [PDF]

				S. Muraro, A. Bondanza, M. Bellone, P. D. Greenberg, and C. Bonini Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4+ and CD8+ T-cell responses Blood, May 1, 2005; 105(9): 3596 - 3604. [Abstract] [Full Text] [PDF]

				F. K. Stevenson, C. H. Ottensmeier, P. Johnson, D. Zhu, S. L. Buchan, K. J. McCann, J. S. Roddick, A. T. King, F. McNicholl, N. Savelyeva, et al. DNA vaccines to attack cancer PNAS, October 5, 2004; 101(suppl_2): 14646 - 14652. [Abstract] [Full Text] [PDF]

				A. Bonehill, C. Heirman, S. Tuyaerts, A. Michiels, K. Breckpot, F. Brasseur, Y. Zhang, P. van der Bruggen, and K. Thielemans Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules J. Immunol., June 1, 2004; 172(11): 6649 - 6657. [Abstract] [Full Text] [PDF]

				E. T. A. Marques Jr., P. Chikhlikar, L. B. de Arruda, I. C. Leao, Y. Lu, J. Wong, J.-S. Chen, B. Byrne, and J. T. August HIV-1 p55Gag Encoded in the Lysosome-associated Membrane Protein-1 as a DNA Plasmid Vaccine Chimera Is Highly Expressed, Traffics to the Major Histocompatibility Class II Compartment, and Elicits Enhanced Immune Responses J. Biol. Chem., September 26, 2003; 278(39): 37926 - 37936. [Abstract] [Full Text] [PDF]

				D. B. DRACHMAN, J-M. WU, A. MIAGKOV, M. A. WILLIAMS, R. N. ADAMS, and B. WU Specific Immunotherapy of Experimental Myasthenia by Genetically Engineered APCs: The "Guided Missile" Strategy Ann. N.Y. Acad. Sci., September 1, 2003; 998(1): 520 - 532. [Abstract] [Full Text] [PDF]

				A. Bonehill, C. Heirman, S. Tuyaerts, A. Michiels, Y. Zhang, P. van der Bruggen, and K. Thielemans Efficient Presentation of Known HLA Class II-restricted MAGE-A3 Epitopes by Dendritic Cells Electroporated with Messenger RNA Encoding an Invariant Chain with Genetic Exchange of Class II-associated Invariant Chain Peptide Cancer Res., September 1, 2003; 63(17): 5587 - 5594. [Abstract] [Full Text] [PDF]

				K. Levesque, Y.-S. Zhao, and E. A. Cohen Vpu Exerts a Positive Effect on HIV-1 Infectivity by Down-modulating CD4 Receptor Molecules at the Surface of HIV-1-producing Cells J. Biol. Chem., July 18, 2003; 278(30): 28346 - 28353. [Abstract] [Full Text] [PDF]

				H. E. Heslop, F. K. Stevenson, and J. J. Molldrem Immunotherapy of Hematologic Malignancy Hematology, January 1, 2003; 2003(1): 331 - 349. [Abstract] [Full Text] [PDF]

				Z. Su, J. Vieweg, A. Z. Weizer, P. Dahm, D. Yancey, V. Turaga, J. Higgins, D. Boczkowski, E. Gilboa, and J. Dannull Enhanced Induction of Telomerase-specific CD4+ T Cells Using Dendritic Cells Transfected with RNA Encoding a Chimeric Gene Product Cancer Res., September 1, 2002; 62(17): 5041 - 5048. [Abstract] [Full Text] [PDF]

				F. Rodriguez, S. Harkins, J. M. Redwine, J. M. de Pereda, and J. L. Whitton CD4+ T Cells Induced by a DNA Vaccine: Immunological Consequences of Epitope-Specific Lysosomal Targeting J. Virol., November 1, 2001; 75(21): 10421 - 10430. [Abstract] [Full Text] [PDF]

				A. Bültmann, W. Muranyi, B. Seed, and J. Haas Identification of Two Sequences in the Cytoplasmic Tail of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein That Inhibit Cell Surface Expression J. Virol., June 1, 2001; 75(11): 5263 - 5276. [Abstract] [Full Text]

				C. Bonini, S. P. Lee, S. R. Riddell, and P. D. Greenberg Targeting Antigen in Mature Dendritic Cells for Simultaneous Stimulation of CD4+ and CD8+ T Cells J. Immunol., April 15, 2001; 166(8): 5250 - 5257. [Abstract] [Full Text] [PDF]

				B. Wu, J.-M. Wu, A. Miagkov, R. N. Adams, H. I. Levitsky, and D. B. Drachman Specific Immunotherapy by Genetically Engineered APCs: The ""Guided Missile"" Strategy J. Immunol., April 1, 2001; 166(7): 4773 - 4779. [Abstract] [Full Text] [PDF]

				C.-C. Chen, A. Rivera, N. Ron, J. P. Dougherty, and Y. Ron A gene therapy approach for treating T-cell-mediated autoimmune diseases Blood, February 15, 2001; 97(4): 886 - 894. [Abstract] [Full Text] [PDF]

				E. Olivetta, K. Pugliese, R. Bona, P. D'Aloja, F. Ferrantelli, A. C. Santarcangelo, G. Mattia, P. Verani, and M. Federico cis Expression of the F12 Human Immunodeficiency Virus (HIV) Nef Allele Transforms the Highly Productive NL4-3 HIV Type 1 to a Replication-Defective Strain: Involvement of both Env gp41 and CD4 Intracytoplasmic Tails J. Virol., January 1, 2000; 74(1): 483 - 492. [Abstract] [Full Text]

				C. Yin, M. S. Wu, C. D. Pauza, and M. S. Salvato High Major Histocompatibility Complex-Unrestricted Lysis of Simian Immunodeficiency Virus Envelope-Expressing Cells Predisposes Macaques to Rapid AIDS Progression J. Virol., May 1, 1999; 73(5): 3692 - 3701. [Abstract] [Full Text]

				S. M. Levitz, S.-H. Nong, K. F. Seetoo, T. S. Harrison, R. A. Speizer, and E. R. Simons Cryptococcus neoformans Resides in an Acidic Phagolysosome of Human Macrophages Infect. Immun., February 1, 1999; 67(2): 885 - 890. [Abstract] [Full Text] [PDF]

				S. A. Thomson, S. R. Burrows, I. S. Misko, D. J. Moss, B. E. H. Coupar, and R. Khanna Targeting a Polyepitope Protein Incorporating Multiple Class II-Restricted Viral Epitopes to the Secretory/Endocytic Pathway Facilitates Immune Recognition by CD4+ Cytotoxic T Lymphocytes: a Novel Approach to Vaccine Design J. Virol., March 1, 1998; 72(3): 2246 - 2252. [Abstract] [Full Text] [PDF]

				A. L. Ruff, F. G. Guarnieri, K. Staveley-O'Carroll, R. F. Siliciano, and J. T. August The Enhanced Immune Response to the HIV gp160/LAMP Chimeric Gene Product Targeted to the Lysosome Membrane Protein Trafficking Pathway J. Biol. Chem., March 28, 1997; 272(13): 8671 - 8678. [Abstract] [Full Text] [PDF]